Traditional Chinese medicine — Atractylodes macrocephala rhizome
Introduction: Atractylodes macrocephala rhizome, the dried rhizome of Atractylodes macrocephala Koidz., is a widely used herbal medicine in China and many other countries. In traditional Chinese medicine, this herb can tonify the Spleen-Qi, and is used to treat distension in the abdomen, loose stools, and diarrhoea. Modern pharmacological studies also demonstrate its great potential in immuno-enhancement and indigestion treatment. The market, yield, and trade volume of Atractylodes macrocephala rhizome are large and develop rapidly in recent years. Atractylodes macrocephala rhizome has been recorded in several pharmacopoeias, including Chinese Pharmacopoeia[1], European Pharmacopoeia[2], Korean Pharmacopoeia[3], Japanese Pharmacopoeia[4] and Hong Kong Chinese Materia Medical Standards[5]. The requirements and specifications in these standards have differences. Therefore, it is important to develop an International Standard for harmonizing the existing standards, as well as ensuring the safety and effectiveness of Atractylodes macrocephala rhizome, which can benefit farmers, consumers, enterprises and governments involved in the cultivation, regulation and trade of Atractylodes macrocephala rhizome. As national implementation may differ, national standards bodies are invited to modify the values given in 5.4 and 5.5 in their national standards. Examples of national and regional values are given in Annex C. © ISO 2024 – All rights reserved
Scope: This document specifies requirements and test methods for Atractylodes macrocephala rhizome that is derived from Atractylodes macrocephala Koidz. It is applicable to Atractylodes macrocephala rhizome that is sold and used as a natural medicine in international trade, including Chinese materia medica (whole medicinal materials) and decoction pieces derived from the plant.